Research ArticleExperimental Studies

Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 – Implications for Clinical Trials

HEIDI TÖRNROOS, HENRY HÄGERSTRAND and CHRISTER LINDQVIST
Anticancer Research January 2019, 39 (1) 107-112; DOI: https://doi.org/10.21873/anticanres.13085

Article Information

vol. 39 no. 1 107-112
DOI 
https://doi.org/10.21873/anticanres.13085
PMID 
30591446
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received October 16, 2018
  • Revision received November 17, 2018
  • Accepted November 21, 2018
  • Published online December 27, 2018.
Copyright & Usage 
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. HEIDI TÖRNROOS,
  2. HENRY HÄGERSTRAND and
  3. CHRISTER LINDQVIST⇑
  1. Cell Biology, Faculty of Natural Sciences and Engineering, Åbo Akademi University, Turku, Finland
  1. Correspondence to: Christer Lindqvist, Cell Biology, Faculty of Natural Sciences and Engineering, Åbo Akademi University, Tykistökatu 6, FIN-20520, Turku, Finland. Tel: +358 22154053, e-mail: clindqvi{at}abo.fi
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 – Implications for Clinical Trials
HEIDI TÖRNROOS, HENRY HÄGERSTRAND, CHRISTER LINDQVIST
Anticancer Research Jan 2019, 39 (1) 107-112; DOI: 10.21873/anticanres.13085
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords